{"protocolSection": {"identificationModule": {"nctId": "NCT02476201", "orgStudyIdInfo": {"id": "CRD_789"}, "organization": {"fullName": "Abbott Medical Devices", "class": "INDUSTRY"}, "briefTitle": "Quartet Lead and Resynchronization Therapy Options III (QUARTO_III)", "officialTitle": "Quartet Lead and Resynchronization Therapy Options - Assessing the Response Rate at 6 Months in CRT Patients Implanted With a Quartet Left Ventricular(LV) Quadripolar Lead and the MultiPoint Pacing (MPP) Feature Activated", "acronym": "QUARTO_III"}, "statusModule": {"statusVerifiedDate": "2022-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2016-02", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-02-13", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2015-06-16", "studyFirstSubmitQcDate": "2015-06-18", "studyFirstPostDateStruct": {"date": "2015-06-19", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2020-04-16", "resultsFirstSubmitQcDate": "2020-07-16", "resultsFirstPostDateStruct": {"date": "2020-08-03", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2022-02-18", "lastUpdatePostDateStruct": {"date": "2022-03-02", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Abbott Medical Devices", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "The purpose of the study is to assess prospectively at 6 months the percentage of responder patients implanted with a Cardiac Resynchronization Therapy (CRT-D) device and a Quartet Left Ventricular (LV) quadripolar lead and with the MultiPoint Pacing (MPP) feature activated.", "detailedDescription": "The primary endpoint of the study is to measure prospectively at 6 months the percentage of responder\\* patients implanted with a Quartet LV quadripolar lead and with the MultiPoint Pacing feature activated compared with No Pacing at baseline.\n\n\\*A positive CRT response is defined as an improvement of more than 15 % in Left Ventricular End Systolic Volume (LVESV) at 6 months post-implant, measured by Echocardiography."}, "conditionsModule": {"conditions": ["Heart Failure"], "keywords": ["Heart Failure", "Cardiac Resynchronization Therapy", "Quadripolar Left Ventricular Lead", "Multipoint Pacing", "Hemodynamic Response"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 105, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "MPP ON", "type": "EXPERIMENTAL", "description": "To activate the Multipoint Pacing (MPP) feature to ON in all patients", "interventionNames": ["Device: MPP ON"]}], "interventions": [{"type": "DEVICE", "name": "MPP ON", "description": "Patients implanted with a Cardiac Resynchronization Therapy CRT-D device and a Quartet Left Ventricular (LV) quadripolar lead and with the MultiPoint Pacing (MPP) feature activated", "armGroupLabels": ["MPP ON"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of CRT Responders", "description": "The number of CRT responders was evaluated at 6 months post-implant. A CRT responder patient was a patient with an improvement of \\>15 % in LVESV, as measured by echocardiography.", "timeFrame": "6 months"}], "secondaryOutcomes": [{"measure": "Changes in LV Echocardiographic Parameters", "description": "An echocardiogram was performed at baseline and at 6 months in subjects with MPP activated. The outcome evaluated the percentage of change in LVESV, left ventricular end-diastolic volume (LVEDV), left ventricular end systolic diameter (LVESD), left ventricular end diastolic diameter (LVEDD), and left ventricular ejection fraction (LVEF) as compared to baseline prior to implant.\n\nThe values of change with positive numbers represent increases and negative numbers represent decreases.", "timeFrame": "Baseline and 6 months"}, {"measure": "Number of CRT Super-responders", "description": "The outcome evaluated the number of CRT super-responders at 6 months in subjects with MPP activated. A super-responder is defined as a subject with a mean absolute LVEF increase of \\>14% at 6 months post-implant compared to baseline.", "timeFrame": "6 months"}, {"measure": "Rates of Hospitalization and Mortality", "description": "The outcome measures rates of all-cause mortality, all-cause hospitalization, cardiovascular hospitalization, and heart failure hospitalization. In addition, the outcome measures the combined endpoint of mortality and heart failure hospitalization and mortality and cardiovascular hospitalization. For the combined endpoints, if a participant experienced both endpoints, they were counted as one participant.", "timeFrame": "6 months"}, {"measure": "Change in NYHA Classification", "description": "The outcome measures status changes in NYHA classification at 6 months for subjects with MPP activated. Subjects experienced either an improvement, worsening, or no change in NYHA classification.\n\nThe NYHA provides a simple way of classifying the extent of heart failure:\n\nNYHA I: No limitation of physical activity. Ordinary physical activity does not cause fatigue, palpitation, dyspnea.\n\nNYHA II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.\n\nNYHA III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.\n\nNYHA IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest.", "timeFrame": "6 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patient that will be implanted with a Cardiac Resynchronization Therapy (CRT-D) with the MultiPoint Pacing (MPP) feature under the current Guidelines indications for CRT-D implant (including upgrades from single or dual chamber Defibrillator or Pacemaker).\n* Patient that will be implanted with a Quartet Left Ventricular (LV) quadripolar lead.\n* In sinus rhythm at baseline visit.\n* Patients with Left Bundle Branch Block (LBBB)\n* Must be willing and able to comply with study requirements.\n* Older than 18 years\n* Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form.\n\nExclusion Criteria:\n\n* Already has a CRT device implanted.\n* Myocardial Infarction or unstable angina within 40 days prior the enrollment.\n* New York Heart Association (NYHA) Class IV\n* Recent cardiac revascularization in the 4 weeks prior to enrollment.\n* Cerebrovascular Accident (CVA) or Transient Ischemic Attack (TIA) in the 3 months prior the enrollment.\n* Classification of Status 1 for cardiac transplantation or consideration for transplantation over the next 12 months.\n* Primary valvular disease requiring surgical intervention.\n* Atrial Fibrillation (AF):\n\n  * Persistent AF at the time of enrollment or 30 days prior the enrollment\n  * Permanent AF not treated with Atrio-Ventricular node ablation within 2 weeks after the CRT-D implant\n  * History or incidence of Paroxysmal or Persistent AF within 30 days prior the enrollment\n* Patient for whom suitable Transthoracic echocardiographic images for determining the cardiac output (CO) and LV volumes cannot be obtained.\n* Undergone a cardiac transplantation or being waiting for it\n* Life expectancy \\< 6 months\n* Pregnancy or planning to become pregnant\n* Unable to comply with the follow up schedule\n* Currently participating in any other clinical investigation.-", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Oscar Sanz", "affiliation": "Abbott Medical", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Hospital Virgen de la Victoria", "city": "Malaga", "country": "Spain", "geoPoint": {"lat": 36.72016, "lon": -4.42034}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "Subject enrollment began on 11-Feb-2016 and the last enrollment occurred on 13-Aug-2018.", "groups": [{"id": "FG000", "title": "MPP ON", "description": "Patients implanted with a Cardiac Resynchronization Therapy CRT-D device and a Quartet Left Ventricular (LV) quadripolar lead will be programmed with the MultiPoint Pacing (MPP) feature activated."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "105"}]}, {"type": "Implant Attempts", "achievements": [{"groupId": "FG000", "numSubjects": "103"}]}, {"type": "Sucessful Implants", "achievements": [{"groupId": "FG000", "numSubjects": "102"}]}, {"type": "6 Months Visit", "achievements": [{"groupId": "FG000", "numSubjects": "82"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "79"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "26"}]}], "dropWithdraws": [{"type": "Unable to program MPP", "reasons": [{"groupId": "FG000", "numSubjects": "9"}]}, {"type": "Study echo not performed", "reasons": [{"groupId": "FG000", "numSubjects": "5"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "4"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "2"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "2"}]}, {"type": "MPP programmed to OFF", "reasons": [{"groupId": "FG000", "numSubjects": "2"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}, {"type": "Unsuccessful implant", "reasons": [{"groupId": "FG000", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "MPP ON", "description": "MPP ON: Subjects implanted with a Cardiac Resynchronization Therapy CRT-D device and a Quartet Left Ventricular (LV) quadripolar lead and with the MultiPoint Pacing (MPP) feature activated."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "64.5", "spread": "8.4"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "27"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "78"}]}]}]}, {"title": "Race and Ethnicity Not Collected", "populationDescription": "Race and Ethnicity were not collected from any participant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Spain", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "97"}]}]}, {"title": "Portugal", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "8"}]}]}]}, {"title": "Left Ventricular End Systolic Volume (LVESV)", "populationDescription": "The number of subjects in this analysis population differs from the overall study population because LVESV was only calculated in the 77 analyzable subjects with 6-month echocardiogram data available.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mililiters", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "77"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "127.78", "spread": "48.87"}]}]}]}, {"title": "New York Heart Association (NYHA) Classification", "description": "The NYHA provides a simple way of classifying the extent of heart failure:\n\nNYHA I: No limitation of physical activity. Ordinary physical activity does not cause fatigue, palpitation, dyspnea.\n\nNYHA II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.\n\nNYHA III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.\n\nNYHA IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "NYHA I", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "6"}]}]}, {"title": "NYHA II", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "60"}]}]}, {"title": "NYHA III", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "39"}]}]}, {"title": "NYHA IV", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Cardiomyopathy Etiology", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Non-ischemic", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "61"}]}]}, {"title": "Ischemic", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "105"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "44"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of CRT Responders", "description": "The number of CRT responders was evaluated at 6 months post-implant. A CRT responder patient was a patient with an improvement of \\>15 % in LVESV, as measured by echocardiography.", "populationDescription": "The analysis population included subjects implanted with a Quartet LV quadripolar lead and with the MPP feature activated and who had a 6-month CRT response evaluation via echocardiography. Subjects who withdrew prior to the 6-month visit, did not complete the 6-month visit, or had relevant 6-month data missing were excluded from the analysis.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MPP ON", "description": "MPP ON: Subjects implanted with a Cardiac Resynchronization Therapy CRT-D device and a Quartet Left Ventricular (LV) quadripolar lead and with the MultiPoint Pacing (MPP) feature activated."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "79"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "53"}]}]}], "analyses": [{"groupIds": ["OG000"], "nonInferiorityType": "SUPERIORITY", "nonInferiorityComment": "Using a one-sided, one sample Exact Binomial Test and a significance level of 2.5%, the study required 74 patients to reach a power of 90%. With the MPP feature activated at baseline, it was assumed that the proportion of responders at 6 months was 75%. The MPP responder rate was compared to 57%, which is the responder rate obtained from literature for patients without the MPP feature activated.", "pValue": "0.0435", "statisticalMethod": "Exact binomial", "paramType": "Percentage", "paramValue": "67.1", "ciPctValue": "97.5", "ciNumSides": "ONE_SIDED", "ciLowerLimit": "55.6"}]}, {"type": "SECONDARY", "title": "Changes in LV Echocardiographic Parameters", "description": "An echocardiogram was performed at baseline and at 6 months in subjects with MPP activated. The outcome evaluated the percentage of change in LVESV, left ventricular end-diastolic volume (LVEDV), left ventricular end systolic diameter (LVESD), left ventricular end diastolic diameter (LVEDD), and left ventricular ejection fraction (LVEF) as compared to baseline prior to implant.\n\nThe values of change with positive numbers represent increases and negative numbers represent decreases.", "populationDescription": "The analysis population included subjects implanted with a Quartet LV quadripolar lead and with the MPP feature activated and who had a 6-month CRT response evaluation via echocardiography. Subjects who withdrew prior to the 6-month visit, did not complete the 6-month visit, or had relevant 6-month data missing were excluded from the analysis.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percent change", "timeFrame": "Baseline and 6 months", "groups": [{"id": "OG000", "title": "MPP ON", "description": "MPP ON: Subjects implanted with a Cardiac Resynchronization Therapy CRT-D device and a Quartet Left Ventricular (LV) quadripolar lead and with the MultiPoint Pacing (MPP) feature activated."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "74"}]}], "classes": [{"title": "LVESV", "categories": [{"measurements": [{"groupId": "OG000", "value": "-25.33", "spread": "31.42"}]}]}, {"title": "LVEDV", "categories": [{"measurements": [{"groupId": "OG000", "value": "-14.90", "spread": "28.09"}]}]}, {"title": "LVESD", "categories": [{"measurements": [{"groupId": "OG000", "value": "-10.72", "spread": "14.53"}]}]}, {"title": "LVEDD", "categories": [{"measurements": [{"groupId": "OG000", "value": "-7.23", "spread": "11.72"}]}]}, {"title": "LVEF", "categories": [{"measurements": [{"groupId": "OG000", "value": "9.37", "spread": "12.2"}]}]}]}, {"type": "SECONDARY", "title": "Number of CRT Super-responders", "description": "The outcome evaluated the number of CRT super-responders at 6 months in subjects with MPP activated. A super-responder is defined as a subject with a mean absolute LVEF increase of \\>14% at 6 months post-implant compared to baseline.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MPP ON", "description": "MPP ON: Subjects implanted with a Cardiac Resynchronization Therapy CRT-D device and a Quartet Left Ventricular (LV) quadripolar lead and with the MultiPoint Pacing (MPP) feature activated."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "77"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "27"}]}]}]}, {"type": "SECONDARY", "title": "Rates of Hospitalization and Mortality", "description": "The outcome measures rates of all-cause mortality, all-cause hospitalization, cardiovascular hospitalization, and heart failure hospitalization. In addition, the outcome measures the combined endpoint of mortality and heart failure hospitalization and mortality and cardiovascular hospitalization. For the combined endpoints, if a participant experienced both endpoints, they were counted as one participant.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "All Enrolled Subjects", "description": "All subjects enrolled in the study are included in this outcome measure."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "105"}]}], "classes": [{"title": "All-cause mortality", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "All-cause hospitalization", "categories": [{"measurements": [{"groupId": "OG000", "value": "12"}]}]}, {"title": "Heart failure hospitalization", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Cardiovascular hospitalization", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}, {"title": "Combined mortality/heart failure hospitalization", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Combined mortality/cardiovascular hospitalization", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}]}]}]}, {"type": "SECONDARY", "title": "Change in NYHA Classification", "description": "The outcome measures status changes in NYHA classification at 6 months for subjects with MPP activated. Subjects experienced either an improvement, worsening, or no change in NYHA classification.\n\nThe NYHA provides a simple way of classifying the extent of heart failure:\n\nNYHA I: No limitation of physical activity. Ordinary physical activity does not cause fatigue, palpitation, dyspnea.\n\nNYHA II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.\n\nNYHA III: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.\n\nNYHA IV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest.", "populationDescription": "Subjects implanted with a CRT-D device and a Quartet quadripolar LV lead, programmed with the MPP feature activated and who had a NYHA classification evaluation at baseline and 6 months.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "MPP ON", "description": "MPP ON: Subjects implanted with a Cardiac Resynchronization Therapy CRT-D device and a Quartet Left Ventricular (LV) quadripolar lead and with the MultiPoint Pacing (MPP) feature activated."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "82"}]}], "classes": [{"title": "Improvement in NYHA classification", "categories": [{"measurements": [{"groupId": "OG000", "value": "26"}]}]}, {"title": "Worsening in NYHA classification", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "NYHA classification unchanged", "categories": [{"measurements": [{"groupId": "OG000", "value": "54"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "6 months", "eventGroups": [{"id": "EG000", "title": "Total Enrolled", "description": "All subjects enrolled in the study are included in the outcome measure.", "deathsNumAffected": 2, "deathsNumAtRisk": 105, "seriousNumAffected": 16, "seriousNumAtRisk": 105, "otherNumAffected": 11, "otherNumAtRisk": 105}], "seriousEvents": [{"term": "Atrial Arrhytmia", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 105}]}, {"term": "Coronary Artery Disease", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Encephalopathy", "organSystem": "Nervous system disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Exacerbation of Heart Failure", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Trauma", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Chest Pain", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Inappropriate shock", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Infection", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Lead dislodgment", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 4, "numAtRisk": 105}]}, {"term": "Pneumothorax/Hemothorax", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Subclavian Vein Thrombus", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Twiddler\u00b4s Syndrome", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Ventricular Arrhythmia", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}], "otherEvents": [{"term": "Allergic reaction", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Hematoma/Seratoma", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Inappropiate shock", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Intermittent pacing", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Lead dislodgement", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 105}]}, {"term": "Oversensing", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 105}]}, {"term": "Pectoral/Diaphragmatic/Phrenic Nerve Stimulation", "organSystem": "Cardiac disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 105}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Pilar Santamaria", "organization": "Abbott Medical", "email": "pilar.santamaria@abbott.com", "phone": "+34 917 278 964"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2015-04-21", "uploadDate": "2020-04-16T10:47", "filename": "Prot_SAP_000.pdf", "size": 7765230}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"browseLeaves": [{"id": "M265601", "name": "Ethinyl estradiol, levonorgestrel drug combination", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}